The complexity of pain in inflammatory arthropathies beyond pain intensity and impact: An OMERACT initiative

Slow acting medications for progressive and painful knee osteoarthritis. How do we assess the benefit to risk of these potentially novel therapies?

Respiratory motion management for external radiotherapy: 2025 update

Radiotherapy for haematological malignancies: Current best practices and advancements

'I couldn't carry on taking a drug like that': a qualitative study of patient perspectives on side effects from rheumatology drugs

Increasing uptake through collaboration in the development of core outcome sets: Lessons learned at OMERACT 2023

Fostering connections at OMERACT 2023: A collaborative approach to Core Outcome Set development

Toward designing human intervention studies to prevent osteoarthritis after knee injury: A report from an interdisciplinary OARSI 2023 workshop

Exploring the complexities of pain phenotypes: OMERACT 2023 chronic pain working group workshop

Embracing unity at OMERACT: Valuing equity, promoting diversity, fostering inclusivity

Optimization of the Eclipse TPS beam configuration parameters for small field dosimetry using Monte Carlo simulations and experimental measurements

Impact of Alcohol on Bone Health in People Living With HIV: Integrating Clinical Data From Serum Bone Markers With Morphometric Analysis in a Non-Human Primate Model

Helical tomotherapy for post-mastectomy radiation therapy with or without breast implant: a single institution experience

Physicians' vs patients' global assessments of disease activity in rheumatology and musculoskeletal trials: A meta-research project with focus on reasons for discrepancies

FDA/Arthritis Foundation osteoarthritis drug development workshop recap: Assessment of long-term benefit

Field output correction factors and electron fluence perturbation of the microSilicon and microSilicon X detectors

Technical note: GAMMORA, a free, open-source, and validated GATE-based model for Monte-Carlo simulations of the Varian TrueBeam

OMERACT 2020: A virtual (R)evolution

Towards the standardization of the absorbed dose report mode in high energy photon beams

The Jak/STAT pathway: A focus on pain in rheumatoid arthritis

A study of the interplay effect in radiation therapy using a Monte-Carlo model

Feasibility and Face Validity of Outcome Measures for Use in Future Studies of Polymyalgia Rheumatica: An OMERACT Study

Disease modification in osteoarthritis; pathways to drug approval

A study of the interplay effect for VMAT SBRT using a four-axes motion phantom

Domains for inclusion in a novel Treatment Response Measure for Systemic Lupus Erythematosus (TRM-SLE): results of a modified Delphi study

Scoping literature review to identify candidate domains for the OMERACT Systemic Lupus Erythematosus core outcome set

OMERACT systemic lupus erythematosus domain survey

OMERACT 2023 Systemic Lupus Erythematosus Special Interest Group: Winnowing and Binning Preliminary Candidate Domains for the Core Outcome Set

Updating the core domains set in Systemic Lupus Erythematosus: Work planned by the Systemic Lupus Erythematosus OMERACT working group

Towards a novel clinical outcome assessment for systemic lupus erythematosus: first outcomes of an international taskforce

What are the domains and outcome measures used in the existing neuropsychiatric systemic lupus erythematosus literature?

What are the domains and outcome measures used in the existing neuropsychiatric systemic lupus erythematosus literature?

The Patients' Perspective of Important Glucocorticoid Effects: A Nominal Group Study Among Patients With Systemic Lupus Erythematosus and Myositis

Measurement properties of selected patient-reported outcome measures for use in randomised controlled trials in patients with systemic lupus erythematosus: a systematic review

Efficacy and safety of a diffusion-based extended-release fluticasone propionate intra-articular injection (EP-104IAR) in knee osteoarthritis (SPRINGBOARD): a 24-week, multicentre, randomised, double-blind, vehicle-controlled, phase 2 trial

Biopsychosocial Rehabilitation for Inflammatory Arthritis and Osteoarthritis Patients: A Systematic Review and Meta-Analysis of Randomized Trials

Harms reported by patients in rheumatology drug trials: a systematic review of randomized trials in the cochrane library from an OMERACT working group

A novel diclofenac gel (AMZ001) applied once or twice daily in subjects with painful knee osteoarthritis: A randomized, placebo-controlled clinical trial

Validity and utility of a single-item patient-reported measure of treatment-related bother in rheumatoid arthritis: A cross-sectional OMERACT study

Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement

Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group

Biopsychosocial Rehabilitation for Inflammatory Arthritis and Osteoarthritis Patients: A Systematic Review and Meta-Analysis of Randomized Trials

Toxoplasmosis in patients with an autoimmune disease and immunosuppressive agents: A multicenter study and literature review

Harms reported by patients in rheumatology drug trials: a systematic review of randomized trials in the cochrane library from an OMERACT working group

Critical appraisal of intra-articular glucocorticoid injections for symptomatic osteoarthritis of the knee

Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set

Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement

Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)

Interleukin-1β inhibitors for the management of acute gout flares: a systematic literature review

Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT working group

Efficacy and safety of a diffusion-based extended-release fluticasone propionate intra-articular injection (EP-104IAR) in knee osteoarthritis (SPRINGBOARD): a 24-week, multicentre, randomised, double-blind, vehicle-controlled, phase 2 trial

Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group

Biopsychosocial Rehabilitation for Inflammatory Arthritis and Osteoarthritis Patients: A Systematic Review and Meta-Analysis of Randomized Trials

Harms reported by patients in rheumatology drug trials: a systematic review of randomized trials in the cochrane library from an OMERACT working group

Prevalence of Renal Impairment in a US Commercially Insured Rheumatoid Arthritis Population: A Retrospective Analysis

Pain Reduction in Rheumatoid Arthritis Patients Who Use Opioids: A Post Hoc Analysis of Phase 3 Trials of Baricitinib

Defining domains: developing consensus-based definitions for foundational domains in OMERACT core outcome sets

Painful Awakening due to Scleroderma Stings

Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)